Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Meningeal Neoplasms × patritumab deruxtecan × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Nonsquamous Non-small Cell Lung Cancer 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Meningeal Neoplasms 1 Brain Neoplasms 1

Interventions

sapanisertib 1 patritumab deruxtecan 1 fludarabine phosphate 1 fludarabine 1 aldesleukin 1 Spinal Puncture 1 Specimen Handling 1 Nivolumab 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Interleukin-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05865990 2026-03-12

TUXEDO-3

MedSIR

Phase 2 Active not recruiting

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡